Friends of the Global Fight

What Friends of the Global Fight does

Friends of the Global Fight Against AIDS, Tuberculosis and Malaria is an independent 501(c)(3) nonprofit advocacy organization headquartered at 1634 Eye Street NW in Washington DC. Its sole functional mandate is to advocate for sustained and increased U.S. government appropriations to the Global Fund to Fight AIDS, Tuberculosis and Malaria, the world's largest multilateral health financing mechanism operating in more than 100 countries. The organization operates as a policy intermediary: it does not develop a technology product, but produces a steady stream of research publications, including the U.S. Investment Case for the Global Fund (FY2027 edition published in early 2026), Global Fund Results Reports (e.g., the September 2025 report documenting 70 million lives saved since 2002), national security issue briefs, HIV sustainability and transition frameworks, and Global Fund 101 educational materials.

The go-to-market motion is a hybrid of direct congressional engagement and coalition-based advocacy. President and CEO Chris Collins provides written and oral testimony to House and Senate Appropriations Subcommittees, and the organization mobilizes three coordinated coalitions: a Faith-Based Coalition of 200+ faith leaders built around Hope Through Healing Hands and former Senator Bill Frist; a Private Sector Coalition of 13+ companies; and partnerships with global health NGOs including the United Nations Foundation, Malaria No More, EGPAF, and the Global Fund Advocacy Network. Recent corporate partnerships span pharma (Gilead Sciences' lenacapavir access agreement, mid-2025) and consumer health (SC Johnson Guardian spatial repellent, 2026).

Revenue flows exclusively from donations and grants to a 501(c)(3) entity with an 11-50 employee headcount; financial details are not publicly disclosed. The customer base is functionally bifurcated: its advocacy targets are U.S. policymakers (Congress, appropriations committees, executive branch agencies), while its donor base comprises individuals, institutional funders, and partner organizations.

Name

Friends of the Global Fight

Legal name

Friends of the Global Fight Against AIDS, Tuberculosis and Malaria

Website

https://theglobalfight.org

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

1–10 employees

Short description

Friends of the Global Fight is a Washington, DC-based 501(c)(3) nonprofit that advocates for sustained U.S. government funding to the Global Fund to Fight AIDS, Tuberculosis and Malaria through congressional testimony, research publications, and coalitions of faith leaders, private sector companies, and global health NGOs.

Ownership category

akta.pro rank

Product category

Global Health Advocacy

NAICS

Voluntary Health Organizations (813212), Social Advocacy Organizations (8133)

SIC

Services-Membership Organizations (8600), Services-Social Services (8300)

akta.pro industry

PRIMARYHLAJAKAC

Global Health Financing Mechanisms

Healthcare & Life Sciences/Public Health, Government & Regulators/Global Health & Development Agencies (NGOs/Multilaterals)

SECONDARYBPAGACAI

Medical Missions & Global Health NGOs

Business & Public Services/Nonprofit, NGO & Social Services/Health & Medical Nonprofits

SECONDARYHLAJAOAA

Multilateral Global Health Partnerships (UN/WHO-led Initiatives)

Healthcare & Life Sciences/Public Health, Government & Regulators/Global Health Initiatives & Partnerships

Keywords

• Global health advocacy
• Public policy advocacy
• Nonprofit advocacy services
• Global health financing
• Congressional appropriations advocacy

Headquarters

HQ city

Washington

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Donations and Grants: Friends of the Global Fight raises funds through donations from individuals and institutional donors to support its advocacy operations. The organization is a registered 501(c)(3) nonprofit.

Go-to-market motion3 records

Distribution channels2 records

Marketing channels7 records

Core offering

Friends of the Global Fight is an independent 501(c)(3) nonprofit advocacy organization that advocates for critical U.S. leadership to end the world's deadliest infectious diseases by influencing U.S. appropriations to the Global Fund to Fight AIDS, Tuberculosis and Malaria. The organization delivers policy advocacy, Congressional testimony, and research publications while mobilizing coalitions of faith leaders and private sector companies. Its deliverables include U.S. Investment Case reports, issue briefs on national security and global health, results reports documenting lives saved, and HIV sustainability and transition frameworks.

Product overview

Friends of the Global Fight is an independent 501(c)(3) nonprofit advocacy organization that advocates for critical U.S. leadership to end the world's deadliest infectious diseases. The organization does not offer a technology product but provides advocacy services, policy publications, and educational materials. Their core offerings include U.S. Investment Case Reports for the Global Fund (detailing the return on U.S. investment in fighting AIDS, TB, and malaria), Global Fund Results Reports (documenting lives saved and treatment outcomes), Issue Briefs on national security and global health connections, HIV Sustainability and Transition Reports, and Global Fund 101 Overview Materials. They also engage in direct policy advocacy and Congressional engagement to shape public policy supporting the Global Fund partnership.

Differentiator

Problem solved

Functional benefit

Products and services

• Policy Advocacy and Public Policy Shaping Services Core advocacy service engaging U.S. policymakers, delivering Congressional testimony, policy analysis, and direct engagement with House and Senate Appropriations Subcommittees to secure funding for the Global Fund.
• Fiscal Year 2027 U.S. Investment Case for the Global Fund Report detailing return on U.S. investment in the Global Fund, including economic benefits, lives saved statistics, and the strategic value of American leadership in global health.
• Global Fund Results Reports Annual reports documenting the Global Fund partnership's impact, including lives saved statistics, treatment numbers, and disease-specific outcomes for HIV, TB, and malaria.
• Issue Brief: How the Global Fund Makes America Stronger and Safer Policy brief highlighting how U.S. leadership in the Global Fund and bilateral programs makes America safer and stronger, connecting global health investment to national security interests.
• HIV Sustainability and Transition Reports Reports outlining principles for responsible transition of American leadership to end AIDS, including guidance on country transition strategies and sustainability frameworks.
• Global Fund 101 Overview Materials Educational materials providing an overview of the Global Fund's unique approach, including information on partnerships, results, and the Global Fund's operational model.

Quantifiable outcome

• The Global Fund partnership has saved 70 million lives since 2002, reducing combined death rate from AIDS, TB and malaria by 63%
• +4 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Twelve partnerships are on record, tiered core and minor.

• SC JohnsoncoreStrategic or Co-development Partner · 1 May 2026Partnership with the Global Fund and U.S. State Department to accelerate rollout of SC Johnson Guardian, the first spatial repellent providing up to 12 months of malaria protection. Initiative aims to protect at least 60 million people from malaria by 2028.
• Gilead SciencescoreStrategic or Co-development Partner · 1 July 2025Partnership to expand access to lenacapavir, a long-acting HIV prevention drug. The Global Fund signed an access agreement with Gilead in mid-2025 to procure lenacapavir for low- and middle-income countries. This marks the first time an HIV prevention product will launch simultaneously in low-income and high-income countries.
• Private Sector Companies CoalitioncoreGTM or Marketing Partner · 1 April 2025Coalition of 13 companies that sent letters to congressional leaders urging robust contribution to the Global Fund. Represents private sector voice in advocacy for global health funding.
• The Global Fund to Fight AIDS, Tuberculosis and MalariacoreStrategic or Co-development PartnerThe Global Fund is the primary focus of Friends' advocacy efforts. Friends advocates for U.S. appropriations to the Global Fund, which invests over $4 billion annually to support programs in 100+ countries fighting AIDS, TB, and malaria. The Global Fund provides matching requirements where every $1 from the U.S. is matched by $2 from other donors.
• PEPFAR (President's Emergency Plan for AIDS Relief)coreStrategic or Co-development PartnerPEPFAR is the U.S. bilateral program working in coordination with the Global Fund. Friends advocates for sustained PEPFAR funding and works to ensure coordination between bilateral and multilateral programs.
• CepheidminorStrategic or Co-development PartnerGlobal Fund has partnered with Cepheid, a California-based company, to lower prices for TB testing through improved access to diagnostic technologies.
• Hope Through Healing HandscoreGTM or Marketing PartnerFaith-based coalition founded and chaired by former Senator Bill Frist (R-TN). Friends partners with Hope Through Healing Hands to bring faith community members to Washington to advocate for global health funding.
• Faith-Based Coalition for the Global FundcoreGTM or Marketing PartnerCoalition of 200+ faith leaders who collectively advocate for Global Fund appropriations through letter-writing campaigns to Congress.
• United Nations Foundation / United to Beat MalariaminorStrategic or Co-development PartnerPartnership for malaria advocacy and co-publishing of reports. Friends co-published a report on country-led malaria control with United to Beat Malaria and Malaria No More.
• Malaria No MoreminorStrategic or Co-development PartnerCo-publishing partner for malaria control reports and advocacy initiatives.
• Elizabeth Glaser Pediatric AIDS Foundation (EGPAF)minorStrategic or Co-development PartnerPartnership focused on pediatric HIV care. Friends references EGPAF analysis on PEPFAR data showing gaps in services for children.
• Global Fund Advocacy Network (GFAN)minorGTM or Marketing PartnerPartner for advocacy coordination and network support for global health financing.

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Friends of the Global Fund (UK): UK-based counterpart that advocates with the UK government and Parliament for Global Fund replenishment. Most directly comparable peer in terms of mission, structure, and operating model.
• ONE Campaign: Global advocacy organization campaigning against extreme poverty and preventable disease, with active U.S. policy advocacy that overlaps with Friends' appropriations work on global health programs.
• Global Fund Advocacy Network (GFAN): Network of advocates supporting Global Fund replenishment across donor countries. Directly comparable in mission; Friends is a member and partner of GFAN.
• Malaria No More: U.S.-based advocacy nonprofit focused on ending malaria deaths; co-publishes reports with Friends and operates in adjacent advocacy space targeting U.S. policymakers.
• RESULTS: Grassroots advocacy organization mobilizing citizens to lobby Congress on poverty and global health issues, including tuberculosis and HIV. Comparable citizen-advocacy model targeting the same appropriations committees.
• Treatment Action Group (TAG): Independent AIDS research and policy advocacy organization engaging with global health funders and policymakers. Operates with a similar small-team advocacy model targeting HIV/TB funding decisions.

Broad incumbents

• amfAR (Foundation for AIDS Research): Well-established AIDS-focused nonprofit that conducts both research funding and policy advocacy in Washington, DC. Larger and broader than Friends but operating in overlapping HIV advocacy territory.
• Global Health Council: Membership-based advocacy organization representing global health organizations before U.S. policymakers. Operates in the same Washington DC advocacy ecosystem with overlapping Congressional targets.
• Elizabeth Glaser Pediatric AIDS Foundation (EGPAF): Major HIV/AIDS organization conducting both service delivery and policy advocacy; partner of Friends and active in U.S. global-health funding advocacy.
• United Nations Foundation: Major advocacy and grantmaking organization supporting UN-led global health initiatives; co-publishes reports with Friends via its United to Beat Malaria campaign.

Market position

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@FriendsGlobalFight
• LinkedInlinkedin.com/company/friends-of-the-global-fight-against-aids-tuberculosis-and-malaria
• Xx.com/theglobalfight
• Facebookfacebook.com/Friends-of-the-Global-Fight-Agains

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Friends of the Global Fight